Opening book details…
About this Biochemistry, Genetics and Molecular Biology article
How to treat CML patients in the tyrosine kinase inhibitors era? From imatinib standard dose to second generation drugs front-line: Unmet needs, pitfalls and advantages by Massimo Breccia; Giuliana Alimena is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- Massimo Breccia; Giuliana Alimena
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0304-3835)
- Published
- 2012
- Language
- EN
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)